<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00309517</url>
  </required_header>
  <id_info>
    <org_study_id>ABSCG 92</org_study_id>
    <nct_id>NCT00309517</nct_id>
  </id_info>
  <brief_title>Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C</brief_title>
  <official_title>A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C (pT2, pN1-3; pT3-4, pN0-3; M0.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Austrian Breast &amp; Colorectal Cancer Study Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Austrian Breast &amp; Colorectal Cancer Study Group</source>
  <brief_summary>
    <textblock>
      This clinical investigation examined the influence of preoperative radiotherapy in
      combination with postoperative 5-fluorouracil + leucovorin chemotherapy vs. 5-fluorouracil +
      leucovorin + MAb 17-1A chemo-immunotherapy on patientsâ€™ local recurrence rate and overall
      survival time following surgery for rectal carcinoma Dukes B or C (T2-4, N0-3, M0).
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>July 1997</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local recurrence-free survival</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival</measure>
  </primary_outcome>
  <enrollment>700</enrollment>
  <condition>Rectal Cancer Dukes B, Dukes C</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluourouracil</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Leucovorin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MAb 17-1A</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with histologically verified operable rectal cancer Dukes B and C (Stage II,
             T2-4, N0-3, M0), R0

          -  Age: 18-80 years

          -  Karnofsky Performance Status &gt; 80

          -  Adequate bone marrow reserve (leukocytes &gt; 4,000, thrombocytes &gt; 105/mm3, Hb &gt; 10g %),
             renal and hepatic functions (total bilirubin and creatinine &lt; 1.25 x ULN)

        Exclusion Criteria:

          -  Colon cancer

          -  R1, R2; carcinosis peritonei

          -  Start of treatment &gt; 42 days postop; other adjuvant radiotherapy, chemotherapy or
             immunotherapy

          -  Previous application of a murine or chimeric monoclonal antibody or antibody fragment

          -  Medical therapy with steroids, cyclosporin or antithymocyte globulin within 3 months
             pre-study

          -  Known hypersensitivity to animal protein

          -  Serious concomitant disease: HIV, chronically inflammatory intestine, diabetes mell.
             gravis, cerebral seizure disorder, et al.

          -  Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raimund Jakesz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Austrian Breast &amp; Colorectal Cancer Study Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Oberpullendorf</name>
      <address>
        <city>Oberpullendorf</city>
        <state>Burgenland</state>
        <zip>7350</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Baden</name>
      <address>
        <city>Baden bei Wien</city>
        <state>Lower Austria</state>
        <zip>2500</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Hainburg</name>
      <address>
        <city>Hainburg</city>
        <state>Lower Austria</state>
        <zip>2410</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Wiener Neustadt, Surgery</name>
      <address>
        <city>Wiener Neustadt</city>
        <state>Lower Austria</state>
        <zip>2700</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Graz, Oncology</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital Linz</name>
      <address>
        <city>Linz</city>
        <state>Upper Austria</state>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital BHB Linz</name>
      <address>
        <city>Linz</city>
        <state>Upper Austria</state>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Vienna, General Hospital</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <link>
    <url>http://www.abcsg.at</url>
  </link>
  <verification_date>October 2000</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2006</study_first_submitted>
  <study_first_submitted_qc>March 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2006</study_first_posted>
  <last_update_submitted>March 31, 2006</last_update_submitted>
  <last_update_submitted_qc>March 31, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 3, 2006</last_update_posted>
  <keyword>Fluorouracil</keyword>
  <keyword>Leucovorin</keyword>
  <keyword>MAb 17-1A</keyword>
  <keyword>Rectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

